MedPath

Rexulti

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015

Approved
Approval ID

2d301358-6291-4ec1-bd87-37b4ad9bd850

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 15, 2023

Manufacturers
FDA

Otsuka America Pharmaceutical, Inc.

DUNS: 008314390

Products 8

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

brexpiprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59148-035
Application NumberNDA205422
Product Classification
M
Marketing Category
C73594
G
Generic Name
brexpiprazole
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2023
FDA Product Classification

INGREDIENTS (13)

brexpiprazoleActive
Quantity: 0.25 mg in 1 1
Code: 2J3YBM1K8C
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 2165RE0K14
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT

brexpiprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59148-038
Application NumberNDA205422
Product Classification
M
Marketing Category
C73594
G
Generic Name
brexpiprazole
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2023
FDA Product Classification

INGREDIENTS (12)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
brexpiprazoleActive
Quantity: 2 mg in 1 1
Code: 2J3YBM1K8C
Classification: ACTIB
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 2165RE0K14
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT

brexpiprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59148-036
Application NumberNDA205422
Product Classification
M
Marketing Category
C73594
G
Generic Name
brexpiprazole
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2023
FDA Product Classification

INGREDIENTS (12)

brexpiprazoleActive
Quantity: 0.5 mg in 1 1
Code: 2J3YBM1K8C
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 2165RE0K14
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

brexpiprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59148-039
Application NumberNDA205422
Product Classification
M
Marketing Category
C73594
G
Generic Name
brexpiprazole
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2023
FDA Product Classification

INGREDIENTS (12)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 2165RE0K14
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
brexpiprazoleActive
Quantity: 3 mg in 1 1
Code: 2J3YBM1K8C
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

brexpiprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59148-037
Application NumberNDA205422
Product Classification
M
Marketing Category
C73594
G
Generic Name
brexpiprazole
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2023
FDA Product Classification

INGREDIENTS (11)

brexpiprazoleActive
Quantity: 1 mg in 1 1
Code: 2J3YBM1K8C
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 2165RE0K14
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

BREXPIPRAZOLE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59148-044
Application NumberNDA205422
Product Classification
M
Marketing Category
C73594
G
Generic Name
BREXPIPRAZOLE
Product Specifications
Effective DateMay 15, 2023
FDA Product Classification

BREXPIPRAZOLE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59148-042
Application NumberNDA205422
Product Classification
M
Marketing Category
C73594
G
Generic Name
BREXPIPRAZOLE
Product Specifications
Effective DateMay 15, 2023
FDA Product Classification

brexpiprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59148-040
Application NumberNDA205422
Product Classification
M
Marketing Category
C73594
G
Generic Name
brexpiprazole
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2023
FDA Product Classification

INGREDIENTS (10)

MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
brexpiprazoleActive
Quantity: 4 mg in 1 1
Code: 2J3YBM1K8C
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 2165RE0K14
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Rexulti - FDA Drug Approval Details